NCT01992380View on ClinicalTrials.gov

A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 13, 2013

Primary Completion Date

May 30, 2014

Study Completion Date

May 30, 2014

Conditions
Alzheimer's Disease
Interventions
DRUG

Flortaucipir F18

IV injection, 370 MBq (10 mCi), two doses up to four weeks apart

PROCEDURE

Brain PET scan

positron emission tomography (PET) scan of the brain at 80-100 and 110-130 minutes after injection

Trial Locations (2)

92663

Research Site, Newport Beach

06510

Research Site, New Haven

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY